Hillsdale Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-6,350
Closed -$599K 703
2019
Q1
$599K Buy
6,350
+870
+16% +$76.1K 0.05% 235
2018
Q4
$351K Buy
5,480
+1,000
+22% +$73.8K 0.04% 355
2018
Q3
$401K Buy
4,480
+500
+13% +$44.2K 0.05% 231
2018
Q2
$316K Buy
3,980
+2,080
+109% +$173K 0.04% 282
2018
Q1
$169K Hold
1,900
0.02% 276
2017
Q4
$198K Hold
1,900
0.03% 285
2017
Q3
$277K Buy
1,900
+1,000
+111% +$136K 0.05% 283
2017
Q2
$117K Hold
900
0.02% 304
2017
Q1
$112K Hold
900
0.02% 295
2016
Q4
$104K Hold
900
0.02% 301
2016
Q3
$94K Hold
900
0.02% 306
2016
Q2
$89K Hold
900
0.03% 322
2016
Q1
$90K Hold
900
0.03% 312
2015
Q4
$108K Hold
900
0.04% 310
2015
Q3
$97K Sell
900
-1,600
-64% -$199K 0.03% 397
2015
Q2
$289K Sell
2,500
-400
-14% -$45.7K 0.09% 269
2015
Q1
$334K Sell
2,900
-40
-1% -$4.78K 0.09% 252
2014
Q4
$329K Sell
2,940
-300
-9% -$31.6K 0.08% 213
2014
Q3
$307K Sell
3,240
-500
-13% -$45.1K 0.1% 185
2014
Q2
$321K Sell
3,740
-1,200
-24% -$91.3K 0.07% 199
2014
Q1
$345K Hold
4,940
0.1% 146
2013
Q4
$417K Sell
4,940
-1,000
-17% -$79.1K 0.12% 121
2013
Q3
$458K Sell
5,940
-1,000
-14% -$70.1K 0.14% 104
2013
Q2
$406K Buy
+6,940
New +$418K 0.13% 99

Other funds holding CELG

Hillsdale Investment Management's CELG Position: Q2 2019 in Review

Hillsdale Investment Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 6,350 shares — an estimated $599K sold.

Hillsdale Investment Management first reported a position in CELG in Q2 2013 and held it in 24 quarters. The position peaked at $599K in Q1 2019. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Hillsdale Investment Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Hillsdale Investment Management sold 6,350 Celgene Corp shares in Q2 2019, an estimated $599K.
  • Hillsdale Investment Management first reported a position in Celgene Corp in Q2 2013 and held it in 24 quarters.
  • Hillsdale Investment Management's Celgene Corp position peaked at $599K in Q1 2019.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Hillsdale Investment Management's 13F filing for Q2 2019, filed 2 Aug 2019.